SCHEMBL3175236

SCHEMBL3175236

C=CCC(=C)OC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11126446 0.82 ALDH1A1 (0.41)
SCHEMBL31150 0.81 TSHR (0.33)
SCHEMBL3400859 0.78
SCHEMBL21811862 0.77
SCHEMBL1049922 0.76 ALOX15 (0.31)
SCHEMBL28226113 0.76 HCAR2 (0.41)
Ethylene Glycol SCHEMBL7523660 0.74 TSHR (0.35)
SCHEMBL11122611 0.73 LMNA (0.32)
Ethylene Glycol SCHEMBL7521890 0.72 TSHR (0.33)
SCHEMBL2138366 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3092220-B1 VITAMIN C PRODRUGS AND USES THEREOF UNIV FLORIDA (US) 2021-01-20 EP claimed
EP-2016044-B1 PENTACYCLINE DERIVATIVES FOR THE TREATMENT OF INFECTIONS HARVARD COLLEGE (US) 2020-06-10 EP claimed
CN-111825611-B 4(1H) -quinovone derivatives and uses thereof 刘扶东 2022-09-09 CN disclosed
CN-114585370-A Oligonucleotide compositions and methods of use thereof 波涛生命科学有限公司 2022-06-03 CN disclosed
CN-114585737-A Oligonucleotide compositions and methods of use thereof 波涛生命科学有限公司 2022-06-03 CN disclosed
CN-114502177-A Oligonucleotide compositions and methods of use thereof 波涛生命科学有限公司 2022-05-13 CN disclosed
CN-113748116-A Techniques useful for oligonucleotide preparation 波涛生命科学有限公司 2021-12-03 CN disclosed
CN-113444086-A Ezh2 inhibitor and application thereof 达纳-法伯癌症研究所股份有限公司 2021-09-28 CN disclosed
CN-113383078-A Oligonucleotide compositions and methods thereof 波涛生命科学有限公司 2021-09-10 CN disclosed
CN-107427521-B Inhibitors of cyclin dependent kinases 达纳-法伯癌症研究所股份有限公司 2021-08-03 CN disclosed
CN-112218664-A Oligonucleotide compositions and methods of use thereof 波涛生命科学有限公司 2021-01-12 CN disclosed
CN-112004928-A Oligonucleotide compositions and methods of use thereof 波涛生命科学有限公司 2020-11-27 CN disclosed
CN-110698460-A Heteroaryl compound, preparation method, pharmaceutical composition and application thereof 隆泰申医药科技(南京) 有限公司 2020-01-17 CN disclosed
CN-105849099-B Polycyclic inhibitors of cyclin dependent kinase 7(CDK7) 达纳-法伯癌症研究所股份有限公司 2020-01-17 CN disclosed
CN-109136974-B C (sp) -containing2) Process for producing (E) -N bond compound 中国科学院上海有机化学研究所 2019-12-31 CN disclosed
CN-110582282-A Triterpene saponin analogues 佐剂技术公司 2019-12-17 CN disclosed
US-20100261908-A1 PROCESSES FOR THE PREPARATION OF PRASUGREL , AND ITS SALTS AND POLYMORPHS DR. REDDY'S LABORATORIES LTD. (IN) 2010-10-14 US disclosed
EP-2205611-A2 PROCESSES FOR THE PREPARATION OF PRASUGREL, AND ITS SALTS AND POLYMORPHS Dr. Reddy's Laboratories Ltd. (IN) 2010-07-14 EP disclosed
WO-2009062044-A2 PROCESSES FOR THE PREPARATION OF PRASUGREL, AND ITS SALTS AND POLYMORPHS DR. REDDY'S LABORATORIES LTD. (IN) 2009-05-14 WO disclosed